Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design
The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an...
Saved in:
Published in | The FASEB journal Vol. 22; no. 10; pp. 3638 - 3647 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Federation of American Societies for Experimental Biology
01.10.2008
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.--Ng, A. K.-L., Zhang, H., Tan, K., Li, Z., Liu, J.-h., Chan, P. K.-S., Li, S.-M., Chan, W.-Y., Au, S. W.-N., Joachimiak, A., Walz, T., Wang, J.-H., Shaw, P.-C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. |
---|---|
AbstractList | The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-A crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development. The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3-Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397-401, 429-437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73-91) located in an arginine-rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine-rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring-shaped assembly of nine NP subunits to model the miniribonucleoprotein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA-binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.--Ng, A. K.-L., Zhang, H., Tan, K., Li, Z., Liu, J.-h., Chan, P. K.-S., Li, S.-M., Chan, W.-Y., Au, S. W.-N., Joachimiak, A., Walz, T., Wang, J.-H., Shaw, P.-C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. |
Author | Li, Zongli Wang, Jia-Huai Tan, Kemin Chan, Paul Kay-Sheung Au, Shannon Wing-Ngor Joachimiak, Andrzej Shaw, Pang-Chui Walz, Thomas Zhang, Hongmin Li, Sui-Mui Chan, Wood-Yee Ng, Andy Ka-Leung Liu, Jin-huan |
Author_xml | – sequence: 1 fullname: Ng, Andy Ka-Leung – sequence: 2 fullname: Zhang, Hongmin – sequence: 3 fullname: Tan, Kemin – sequence: 4 fullname: Li, Zongli – sequence: 5 fullname: Liu, Jin-huan – sequence: 6 fullname: Chan, Paul Kay-Sheung – sequence: 7 fullname: Li, Sui-Mui – sequence: 8 fullname: Chan, Wood-Yee – sequence: 9 fullname: Au, Shannon Wing-Ngor – sequence: 10 fullname: Joachimiak, Andrzej – sequence: 11 fullname: Walz, Thomas – sequence: 12 fullname: Wang, Jia-Huai – sequence: 13 fullname: Shaw, Pang-Chui |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18614582$$D View this record in MEDLINE/PubMed |
BookMark | eNo10MlOwzAUhWELgWgL7FiDH4DAvU7sOOyqikmqisSwrjwWV6ldOQkCnh5EYXU2n87in5D9mKIj5BThEqERV359CbJAZIiwR8bISyiEFLBPxiAbVghRyhGZdN0aABBQHJIRSoEVl2xMPp77PJh-yI4mT_s3R0P07eDil6LvIQ8dndJ7vkAaB9O6tM2pdyFe07DZtsGoPqTYUZ8yfVpMqQ7Rhri6oKkNq7RxOXz9iguqoqXvypgQHbWuC6t4TA68ajt38rdH5OX25mV2X8wf7x5m03lhuKygsNaU6JpaaF57ry1jQpZlU1ngvpHeMNBGW21q5YRAXdcCdGVMozlyMIwdkbPd7XbQG2eX2xw2Kn8u_wv8gPMd8Cot1SqHbvn6zABLQF7VTcnZNysUaX8 |
CitedBy_id | crossref_primary_10_1016_j_virol_2010_10_001 crossref_primary_10_1007_s13238_012_2087_5 crossref_primary_10_1038_s41598_017_13784_4 crossref_primary_10_3390_ijms232113613 crossref_primary_10_1021_acs_jmedchem_8b00557 crossref_primary_10_1128_JVI_00073_12 crossref_primary_10_1371_journal_pone_0239899 crossref_primary_10_1007_s12551_017_0333_z crossref_primary_10_7554_eLife_26910 crossref_primary_10_1016_j_febslet_2013_02_048 crossref_primary_10_1128_MMBR_00011_14 crossref_primary_10_1016_j_bbrc_2020_02_059 crossref_primary_10_1128_JVI_00583_15 crossref_primary_10_1126_science_1227270 crossref_primary_10_1093_nar_gks1181 crossref_primary_10_1128_JVI_01424_08 crossref_primary_10_1016_j_virol_2018_09_005 crossref_primary_10_1093_nar_gkae1211 crossref_primary_10_4049_jimmunol_1501565 crossref_primary_10_1016_j_virol_2012_06_016 crossref_primary_10_3389_fmicb_2017_01308 crossref_primary_10_1016_j_drudis_2012_06_002 crossref_primary_10_1128_mBio_01224_17 crossref_primary_10_3109_1040841X_2013_826177 crossref_primary_10_1371_journal_pone_0030038 crossref_primary_10_1371_journal_pone_0036415 crossref_primary_10_1016_j_vaccine_2012_09_079 crossref_primary_10_1016_j_virol_2010_01_036 crossref_primary_10_1016_j_virol_2015_06_032 crossref_primary_10_4236_wjv_2012_23017 crossref_primary_10_1093_nar_gkr985 crossref_primary_10_7554_eLife_00631 crossref_primary_10_2217_fmb_13_128 crossref_primary_10_1039_c3mb70268e crossref_primary_10_1371_journal_pone_0149986 crossref_primary_10_1371_journal_ppat_1000491 crossref_primary_10_1016_j_virusres_2012_04_003 crossref_primary_10_1073_pnas_1314781111 crossref_primary_10_1099_vir_0_010660_0 crossref_primary_10_1073_pnas_1113107108 crossref_primary_10_1128_JVI_00825_17 crossref_primary_10_1128_mBio_01569_16 crossref_primary_10_1007_s00253_023_12433_3 crossref_primary_10_1016_j_biochi_2011_11_009 crossref_primary_10_1016_j_vaccine_2012_04_085 crossref_primary_10_1099_vir_0_055053_0 crossref_primary_10_3851_IMP2235 crossref_primary_10_1016_j_bbrc_2013_11_100 crossref_primary_10_1128_JVI_00014_12 crossref_primary_10_3390_v8090247 crossref_primary_10_4161_rna_29730 crossref_primary_10_1007_s10930_015_9601_6 crossref_primary_10_1134_S1027451016020063 crossref_primary_10_1016_j_micinf_2010_01_001 crossref_primary_10_1021_acs_jmedchem_4c01540 crossref_primary_10_1021_acs_jmedchem_9b01244 crossref_primary_10_1128_JVI_02332_14 crossref_primary_10_1089_vim_2010_0088 crossref_primary_10_1002_jmr_1004 crossref_primary_10_1038_nsmb_1779 crossref_primary_10_1093_nar_gkac410 crossref_primary_10_1128_jvi_01972_23 crossref_primary_10_1016_j_ejcb_2015_05_012 crossref_primary_10_1073_pnas_1108515108 crossref_primary_10_1517_13543776_2013_831073 crossref_primary_10_1128_JVI_02406_14 crossref_primary_10_1128_MMBR_00024_13 crossref_primary_10_1093_nar_gkab203 crossref_primary_10_1016_j_virol_2019_08_002 crossref_primary_10_3390_v16091447 crossref_primary_10_3390_v16030421 crossref_primary_10_1038_srep15055 crossref_primary_10_1128_jvi_01757_21 crossref_primary_10_1128_JVI_02474_09 crossref_primary_10_1371_journal_ppat_1004826 crossref_primary_10_1371_journal_ppat_1003624 crossref_primary_10_1126_science_1228172 crossref_primary_10_1111_cmi_12679 crossref_primary_10_1126_sciadv_adl6144 crossref_primary_10_1586_erv_10_52 crossref_primary_10_1016_j_virol_2008_11_048 crossref_primary_10_1128_JVI_00695_11 crossref_primary_10_1038_srep29684 crossref_primary_10_1016_j_virol_2017_03_015 crossref_primary_10_1371_journal_pbio_3000008 crossref_primary_10_1128_JVI_02562_10 crossref_primary_10_1073_pnas_1200808109 crossref_primary_10_1371_journal_pone_0191226 crossref_primary_10_1038_s41598_017_17458_z crossref_primary_10_1016_j_virol_2015_03_018 crossref_primary_10_1038_ncomms2589 crossref_primary_10_1016_j_meegid_2015_06_030 crossref_primary_10_1016_j_virusres_2013_05_010 crossref_primary_10_1038_ncomms4259 crossref_primary_10_1007_s13238_013_3901_4 crossref_primary_10_1073_pnas_1107906108 crossref_primary_10_1371_journal_ppat_1000462 crossref_primary_10_1128_JVI_01861_18 crossref_primary_10_3390_v4102137 crossref_primary_10_1002_pro_70093 crossref_primary_10_1371_journal_ppat_1006288 crossref_primary_10_1016_j_aca_2018_11_055 crossref_primary_10_1016_j_bbrc_2014_12_092 crossref_primary_10_1128_jvi_00205_22 crossref_primary_10_1002_rmv_666 crossref_primary_10_3390_v12080834 crossref_primary_10_1080_07391102_2014_979230 crossref_primary_10_1038_s41423_022_00862_5 crossref_primary_10_1517_17460441_2012_674510 crossref_primary_10_1002_med_21401 crossref_primary_10_1016_j_virol_2010_12_040 crossref_primary_10_1021_acsinfecdis_7b00120 crossref_primary_10_1016_j_tim_2014_04_001 crossref_primary_10_1002_jmv_23812 crossref_primary_10_1016_j_chemphys_2017_11_005 crossref_primary_10_1128_JVI_01634_08 crossref_primary_10_1016_j_vetmic_2010_02_032 crossref_primary_10_1016_j_virol_2016_05_018 crossref_primary_10_1016_j_tim_2013_07_006 crossref_primary_10_3390_biomedicines12112530 crossref_primary_10_1128_JVI_00997_18 crossref_primary_10_2217_fvl_14_45 crossref_primary_10_1007_s11427_009_0064_x crossref_primary_10_1371_journal_pone_0137802 crossref_primary_10_1093_nar_gkaf112 crossref_primary_10_3389_fmicb_2022_869406 crossref_primary_10_1371_journal_ppat_1005062 crossref_primary_10_3389_fphy_2017_00025 crossref_primary_10_1016_j_virol_2014_01_023 crossref_primary_10_1101_cshperspect_a038398 crossref_primary_10_1128_AAC_02335_12 crossref_primary_10_1038_srep19063 crossref_primary_10_1093_nar_gkac688 crossref_primary_10_1128_JVI_05503_11 crossref_primary_10_1371_journal_ppat_1011214 crossref_primary_10_3390_v2010027 crossref_primary_10_3390_v10100522 crossref_primary_10_3390_vaccines10122066 crossref_primary_10_1128_JVI_02048_18 crossref_primary_10_4161_rna_8_2_14513 crossref_primary_10_1371_journal_pone_0173582 crossref_primary_10_1016_j_intimp_2011_08_019 crossref_primary_10_1111_j_1750_2659_2012_00335_x crossref_primary_10_1073_pnas_1306838110 crossref_primary_10_1128_mbio_03315_21 crossref_primary_10_1038_nrmicro_2016_87 crossref_primary_10_1517_17460441_2015_1019859 crossref_primary_10_1016_j_antiviral_2013_07_018 crossref_primary_10_1099_vir_0_017608_0 crossref_primary_10_1371_journal_ppat_1003279 crossref_primary_10_1107_S2053230X2100635X crossref_primary_10_1038_s41564_020_0675_3 crossref_primary_10_1371_journal_ppat_1003275 crossref_primary_10_1021_ac2022426 crossref_primary_10_3390_v16020316 crossref_primary_10_1016_j_ejphar_2017_05_038 crossref_primary_10_1007_s13238_015_0163_3 crossref_primary_10_1128_mBio_00467_12 crossref_primary_10_1016_j_abb_2012_09_006 crossref_primary_10_3390_v14030521 crossref_primary_10_1016_j_virol_2014_06_033 crossref_primary_10_1021_jacs_3c07325 crossref_primary_10_1016_j_mib_2011_07_011 crossref_primary_10_1074_jbc_M112_392878 crossref_primary_10_1128_JVI_00971_21 crossref_primary_10_2222_jsv_59_1 crossref_primary_10_1002_jmv_28968 crossref_primary_10_1016_j_vaccine_2015_09_038 crossref_primary_10_1016_j_str_2024_04_016 crossref_primary_10_3389_fimmu_2022_878943 crossref_primary_10_1016_j_tips_2009_03_002 crossref_primary_10_1038_s41598_018_37306_y crossref_primary_10_3390_vaccines9070739 |
ContentType | Journal Article |
DBID | FBQ CGR CUY CVF ECM EIF NPM |
DOI | 10.1096/fj.08-112110 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1530-6860 |
EndPage | 3647 |
ExternalDocumentID | 18614582 US201301547935 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GroupedDBID | --- -DZ -~X .55 0R~ 0VX 123 18M 1OB 1OC 29H 2WC 33P 34G 39C 3O- 4.4 53G 5GY 5RE 85S AAHHS AANLZ ABCUV ABDNZ ABEFU ABJNI ABOCM ABPTK ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACPRK ACXQS ACYGS ADKYN ADZMN AEEZP AEIGN AENEX AEQDE AEQTP AEUYR AFDAS AFFNX AFFPM AFMIJ AFRAH AGCDD AI. AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB BFHJK C1A CS3 DCZOG DU5 D~5 E3Z EBS EJD F20 F5P F9R FBQ FRP HZ~ H~9 J5H L7B LATKE LEEKS MEWTI MVM NEJ O9- OHT OVD Q-A RHF RHI RJQFR ROL SAMSI SJN SUPJJ TEORI TFA TR2 TWZ VH1 W8F WH7 WHG WOQ WXSBR X7M XJT XOL XSW Y6R YBU YCJ YHG YKV YNH YSK Z0Y ZA5 ZCA ZE2 ZGI ZXP ~KM AAHQN AAMMB AAMNL AAYCA ADXHL AEFGJ AEYWJ AFWVQ AGHNM AGXDD AGYGG AHBTC AIDQK AIDYY AITYG AIZAD ALVPJ BIYOS CGR CUY CVF ECM EIF H13 HGLYW NPM U18 |
ID | FETCH-LOGICAL-c5840-ddc31e976b57ffbd22683394d05f98fc20bcbdbc7ae661b7760b4cc9b5150c22 |
ISSN | 0892-6638 |
IngestDate | Mon Jul 21 06:02:40 EDT 2025 Wed Dec 27 19:19:12 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5840-ddc31e976b57ffbd22683394d05f98fc20bcbdbc7ae661b7760b4cc9b5150c22 |
OpenAccessLink | http://doi.org/10.1096/fj.08-112110 |
PMID | 18614582 |
PageCount | 10 |
ParticipantIDs | pubmed_primary_18614582 fao_agris_US201301547935 |
PublicationCentury | 2000 |
PublicationDate | October 2008 |
PublicationDateYYYYMMDD | 2008-10-01 |
PublicationDate_xml | – month: 10 year: 2008 text: October 2008 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The FASEB journal |
PublicationTitleAlternate | FASEB J |
PublicationYear | 2008 |
Publisher | The Federation of American Societies for Experimental Biology |
Publisher_xml | – name: The Federation of American Societies for Experimental Biology |
References | 4328417 - J Virol. 1971 Jul;8(1):66-73 16011865 - Vaccine. 2005 Nov 16;23(46-47):5404-10 11306552 - EMBO Rep. 2001 Apr;2(4):313-7 16424302 - Science. 2006 Jan 20;311(5759):315-6 11875246 - Bull Hist Med. 2002 Spring;76(1):105-15 16731941 - J Virol. 2006 Jun;80(12):6024-32 16704803 - Emerg Infect Dis. 2006 Apr;12(4):569-74 15103397 - Biol Proced Online. 2004;6:23-34 15572765 - Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 8035510 - J Virol. 1994 Aug;68(8):5108-16 18209073 - J Immunol. 2008 Feb 1;180(3):1758-68 9757107 - Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 8474171 - J Virol. 1993 May;67(5):2723-9 15299374 - Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 11907320 - J Gen Virol. 2002 Apr;83(Pt 4):723-34 10438825 - J Virol. 1999 Sep;73(9):7357-67 16844985 - Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W173-6 17623082 - Virol J. 2007;4:72 17151603 - Nature. 2006 Dec 21;444(7122):1078-82 16855301 - Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66 15163496 - Virus Res. 2004 Jul;103(1-2):97-100 16778023 - Science. 2006 Jul 21;313(5785):360-3 10405371 - Virology. 1999 Jul 20;260(1):190-200 18332179 - J Exp Med. 2008 Mar 17;205(3):711-23 14749182 - Virus Res. 2004 Feb;99(2):169-75 10590102 - J Virol. 2000 Jan;74(1):156-63 18353950 - J Virol. 2008 Jun;82(11):5161-6 16837112 - Vaccine. 2006 Nov 10;24(44-46):6594-6 7966640 - J Virol. 1994 Dec;68(12):8433-6 17176120 - BioDrugs. 2006;20(6):335-40 8806539 - Virology. 1996 Sep 1;223(1):51-6 8039508 - EMBO J. 1994 Jul 1;13(13):3158-65 1824905 - Virology. 1991 Feb;180(2):668-77 16778022 - Science. 2006 Jul 21;313(5785):357-60 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57 9621005 - J Virol. 1998 Jul;72(7):5493-501 14691253 - Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):308-13 16103176 - J Virol. 2005 Sep;79(17):11239-46 12399202 - Vaccine. 2002 Nov 1;20(31-32):3731-8 |
References_xml | – reference: 16011865 - Vaccine. 2005 Nov 16;23(46-47):5404-10 – reference: 8474171 - J Virol. 1993 May;67(5):2723-9 – reference: 11875246 - Bull Hist Med. 2002 Spring;76(1):105-15 – reference: 17176120 - BioDrugs. 2006;20(6):335-40 – reference: 11306552 - EMBO Rep. 2001 Apr;2(4):313-7 – reference: 14691253 - Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):308-13 – reference: 16731941 - J Virol. 2006 Jun;80(12):6024-32 – reference: 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57 – reference: 16837112 - Vaccine. 2006 Nov 10;24(44-46):6594-6 – reference: 16704803 - Emerg Infect Dis. 2006 Apr;12(4):569-74 – reference: 17623082 - Virol J. 2007;4:72 – reference: 8039508 - EMBO J. 1994 Jul 1;13(13):3158-65 – reference: 8035510 - J Virol. 1994 Aug;68(8):5108-16 – reference: 15572765 - Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 – reference: 15299374 - Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 – reference: 16424302 - Science. 2006 Jan 20;311(5759):315-6 – reference: 11907320 - J Gen Virol. 2002 Apr;83(Pt 4):723-34 – reference: 18209073 - J Immunol. 2008 Feb 1;180(3):1758-68 – reference: 9757107 - Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 – reference: 15103397 - Biol Proced Online. 2004;6:23-34 – reference: 9621005 - J Virol. 1998 Jul;72(7):5493-501 – reference: 17151603 - Nature. 2006 Dec 21;444(7122):1078-82 – reference: 10590102 - J Virol. 2000 Jan;74(1):156-63 – reference: 16778023 - Science. 2006 Jul 21;313(5785):360-3 – reference: 16855301 - Acta Crystallogr D Biol Crystallogr. 2006 Aug;62(Pt 8):859-66 – reference: 18353950 - J Virol. 2008 Jun;82(11):5161-6 – reference: 10405371 - Virology. 1999 Jul 20;260(1):190-200 – reference: 16778022 - Science. 2006 Jul 21;313(5785):357-60 – reference: 10438825 - J Virol. 1999 Sep;73(9):7357-67 – reference: 14749182 - Virus Res. 2004 Feb;99(2):169-75 – reference: 12399202 - Vaccine. 2002 Nov 1;20(31-32):3731-8 – reference: 8806539 - Virology. 1996 Sep 1;223(1):51-6 – reference: 16844985 - Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W173-6 – reference: 7966640 - J Virol. 1994 Dec;68(12):8433-6 – reference: 16103176 - J Virol. 2005 Sep;79(17):11239-46 – reference: 18332179 - J Exp Med. 2008 Mar 17;205(3):711-23 – reference: 1824905 - Virology. 1991 Feb;180(2):668-77 – reference: 4328417 - J Virol. 1971 Jul;8(1):66-73 – reference: 15163496 - Virus Res. 2004 Jul;103(1-2):97-100 |
SSID | ssj0001016 |
Score | 2.3812242 |
Snippet | The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and... |
SourceID | pubmed fao |
SourceType | Index Database Publisher |
StartPage | 3638 |
SubjectTerms | Amino Acid Sequence Antiviral Agents - chemistry Antiviral Agents - pharmacology Crystallography, X-Ray Drug Design Influenza A Virus, H5N1 Subtype - chemistry Influenza A Virus, H5N1 Subtype - drug effects Influenza A Virus, H5N1 Subtype - immunology Influenza Vaccines - chemistry Influenza Vaccines - immunology Molecular Sequence Data Nucleoproteins - chemistry Nucleoproteins - drug effects Nucleoproteins - immunology Protein Conformation RNA - chemistry Viral Core Proteins - chemistry Viral Core Proteins - drug effects Viral Core Proteins - immunology |
Title | Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18614582 |
Volume | 22 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZaEBIviPvGZfIDb1lGmnt469Cqio1K0E6aeKlix64ysWSCdWL7H_xfPl_SeuUi4CWq7CaxfL743M8h5BUHVyhkGvuJrBI_TuPCz0PJ_aiMRZonaRXr_Ir3k3R8HL87SU56ve9O1NLygu3x61_mlfwPVTEGuqos2X-g7OqhGMBv0BdXUBjXv6LxVBd_VS4A6-mvTcuR69K7rL8sv-KrHyeTgdeoosWtLslQ60iO2o0jV4GGHydDj9U6w0Vtevu5XrTKl2OSNLsQz8uSKz-8V63DPk7XaBsNpwf7nrtwZWRe2LDJK--w9I_E0nJK11Y9bpvFWb2OCDY22UPhjB3poINPrUo6vmGoyFchb-Az3eEKVTU3_QO60zcMXZQFzlkapabuy0-HPLQuRZnTPfUOVaIucP-GXTw_0wQf5JA9EtPb6M-zGyW3u6k-6UP5UN1UlQnIsndl7rAZFFjIa3cZqgKtvRWiiizbDV1Fyyyz--SeVTbo0CDnAemJ5iG5Y9qPXj0i31b4oa2kwA9d4Ydq_NAhVfihN_DzhrrooUAPBXqoRc8u3cDOLgVyqEUONch5TGajg9nbsW87cfgcAmrgVxWPBgKSK0syKVkFmT2PoiKugkQWueRhwDirGM9KAXmPZVkasJjzgkFaDngYPiG3mrYRW4QOBgw6aZZBMZE4JQrGSyFLDq1fpEJW-TbZwr7NywVY3Px4GirHOqR8cJFkmzw1mzk_N4VY5t1mP_vtzHNydw3FF-S2xJcvXkKMvGA7pD_a_7CjifsDG4xxTw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure+of+the+influenza+virus+A+H5N1+nucleoprotein%3A+implications+for+RNA+binding%2C+oligomerization%2C+and+vaccine+design&rft.jtitle=The+FASEB+journal&rft.au=Ng%2C+Andy+Ka-Leung&rft.au=Zhang%2C+Hongmin&rft.au=Tan%2C+Kemin&rft.au=Li%2C+Zongli&rft.date=2008-10-01&rft.eissn=1530-6860&rft.volume=22&rft.issue=10&rft.spage=3638&rft_id=info:doi/10.1096%2Ffj.08-112110&rft_id=info%3Apmid%2F18614582&rft_id=info%3Apmid%2F18614582&rft.externalDocID=18614582 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon |